Lower doses of oral estrogen and progestogens as treatment for postmenopausal womenARCHER, David F.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 188-195, 8 p.Article

Tissue-Selective Estrogen Complexes: A Promising Option for the Comprehensive Management of Menopausal SymptomsARCHER, David F.Drugs & aging. 2010, Vol 27, Num 7, pp 533-544, issn 1170-229X, 12 p.Article

Menstrual -cycle -related symptoms : a review of the rationale for continuous use of oral contraceptivesARCHER, David F.Contraception (Stoneham). 2006, Vol 74, Num 5, pp 359-366, issn 0010-7824, 8 p.Article

A contemporary approach to the menopauseARCHER, David F.Seminars in reproductive medicine. 2005, Vol 23, Num 2, 85 p.Serial Issue

Alesse^®: leading the shift to 20μgARCHER, David F.American journal of obstetrics and gynecology. 1999, Vol 181, Num 5, issn 0002-9378, 33 p., 2Serial Issue

Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristoneMIRKIN, Sebastian; ARCHER, David F.Contraception (Stoneham). 2004, Vol 70, Num 4, pp 327-333, issn 0010-7824, 7 p.Article

Endometrial bleeding during hormone therapy : The effect of progestogensARCHER, David F.Maturitas (Amsterdam). 2007, Vol 57, Num 1, pp 71-76, issn 0378-5122, 6 p.Conference Paper

Female sexual dysfunction and use of hormone therapy in postmenopausal womenKOVALEVSKY, George.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 180-187, 8 p.Article

Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-a mRNA in Ishikawa cells Implication for tibolone's effects on the endometriumMIRKIN, Sebastian; ARCHER, David F.Maturitas (Amsterdam). 2007, Vol 57, Num 4, pp 338-346, issn 0378-5122, 9 p.Article

Prevention of postmenopausal bone loss and treatment of osteoporosisKLEEREKOPER, Michael.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 141-148, 8 p.Article

Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17β-estradiol on thrombospondin-1 mRNA in Ishikawa cellsMIRKIN, Sebastian; ARCHER, David F.Fertility and sterility. 2004, Vol 82, Num 1, pp 220-222, issn 0015-0282, 3 p.Article

Prevention of coronary heart disease : A nonhormonal approachLEWIS, Vivian; HOEGER, Kathleen.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 157-166, 10 p.Article

Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparationsSTANCZYK, Frank Z; ARCHER, David F.Contraception (Stoneham). 2014, Vol 89, Num 4, pp 242-252, issn 0010-7824, 11 p.Article

Breast cancer : The role of hormone therapyCREASMAN, William T.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 167-171, 5 p.Article

Oral contraceptive efficacy and antibiotic interaction: A myth debunkedARCHER, Johanna S. M; ARCHER, David F.Journal of the American Academy of Dermatology. 2002, Vol 46, Num 6, pp 917-923, issn 0190-9622Article

Effect of 17β-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cellsMIRKIN, Sebastian; WONG, Benjamin C; ARCHER, David F et al.Fertility and sterility. 2005, Vol 84, Num 2, pp 485-491, issn 0015-0282, 7 p.Article

Vaginal hormone therapy for urogenital and menopausal symptomsBALLAGH, Susan A.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 126-140, 15 p.Article

Hormone replacement therapy : Effect of progestin dose and time since menopause on endometrial bleedingARCHER, David F; PICKAR, James H.Obstetrics and gynecology (New York. 1953). 2000, Vol 96, Num 6, pp 899-905, issn 0029-7844Article

The effects on ovarian activity of a monophasic oral contraceptive with 100 μg levonorgestrel and 20 μg ethinyl estradiolCONEY, P; DELCONTE, A.American journal of obstetrics and gynecology. 1999, Vol 181, Num 5, pp S53-S58, issn 0002-9378, 2Article

Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels : A twenty-four-month clinical trialYOUNG, R. L; DELCONTE, A.American journal of obstetrics and gynecology. 1999, Vol 181, Num 5, pp S59-S62, issn 0002-9378, 2Article

Pathophysiology and treatment of menopausal hot flashesFREEDMAN, Robert R.Seminars in reproductive medicine. 2005, Vol 23, Num 2, pp 117-125, 9 p.Article

Effect of raloxifene, 17β-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cellsNAVARRO, Francisco J; MIRKIN, Sebastian; ARCHER, David F et al.Fertility and sterility. 2003, Vol 79, Num 6, pp 1409-1415, issn 0015-0282, 7 p.Article

Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg (Loestrin® 24 Fe)NAKAJIMA, Steven T; ARCHER, David F; ELLMAN, Herman et al.Contraception (Stoneham). 2007, Vol 75, Num 1, pp 16-22, issn 0010-7824, 7 p.Article

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trialARCHER, David F; STANCZYK, Frank Z; RUBIN, Arkady et al.Contraception (Stoneham). 2012, Vol 85, Num 6, pp 595-601, issn 0010-7824, 7 p.Article

Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokineRONGXIU LI; XIAOPING LUO; ARCHER, David F et al.Journal of reproductive immunology. 2007, Vol 73, Num 2, pp 118-129, issn 0165-0378, 12 p.Article